SHENKMAN CAPITAL MANAGEMENT INC - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 39 filers reported holding NEUROCRINE BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SHENKMAN CAPITAL MANAGEMENT INC ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q2 2022$813,000
-85.3%
611,000
-85.3%
0.05%
-93.0%
Q1 2022$5,528,000
+0.7%
4,166,000
-4.4%
0.70%
+86.9%
Q4 2021$5,487,000
+2.3%
4,360,000
+9.3%
0.37%
-9.0%
Q3 2021$5,362,000
-9.5%
3,990,000
-8.6%
0.41%
-24.1%
Q2 2021$5,924,000
-9.8%
4,366,000
-9.0%
0.54%
-29.5%
Q1 2021$6,565,000
+7.4%
4,796,000
+9.8%
0.77%
+20.1%
Q4 2020$6,113,000
+2.4%
4,369,000
+2.6%
0.64%
-9.6%
Q3 2020$5,971,000
-13.8%
4,258,000
+3.8%
0.71%
-28.8%
Q2 2020$6,923,000
+35.4%
4,101,000
+4.6%
0.99%
+29.5%
Q1 2020$5,113,000
+2.4%
3,920,000
+21.5%
0.76%
+17.9%
Q4 2019$4,993,000
-8.7%
3,226,000
-18.2%
0.65%
+3.8%
Q3 2019$5,469,000
+5.3%
3,943,000
+0.4%
0.62%
+6.1%
Q2 2019$5,193,000
-6.9%
3,927,000
-4.7%
0.59%
-17.9%
Q1 2019$5,579,000
+19.1%
4,121,000
+5.2%
0.72%
+4.7%
Q4 2018$4,686,000
-31.1%
3,917,000
-1.7%
0.68%
-16.9%
Q3 2018$6,799,000
+6.3%
3,983,000
-10.0%
0.82%
+6.7%
Q2 2018$6,397,0004,425,0000.77%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
III Capital Management 12,500,000$17,262,0003.12%
CSS LLC/IL 24,395,000$33,616,0001.59%
Mint Tower Capital Management B.V. 9,000,000$12,407,0001.46%
Context Partners Fund, L.P. 3,000,000$4,125,0000.90%
Context Capital Management, LLC 3,000,000$4,125,0000.90%
SHENKMAN CAPITAL MANAGEMENT INC 4,258,000$5,971,0000.71%
SSI INVESTMENT MANAGEMENT LLC 5,888,000$8,100,0000.70%
Aequim Alternative Investments LP 3,000,000$4,155,0000.55%
WOLVERINE ASSET MANAGEMENT LLC 32,181,000$44,437,0000.40%
TWO SIGMA SECURITIES, LLC 13,000,000$17,875,0000.36%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders